We report the unusual complication of vaginal stenosis occurring after allogeneic bone marrow transplantation (BMT) for leukaemia. This was in all likelihood a manifestation of chronic graft-versus-host disease (cGVHD), although the patient has no other stigmata of this and suffered little acute graft-versus-host disease (aGVHD) after BMT. Other risk factors for vaginal stenosis were considered and appear to be absent in this patient, although the total body irradiation used as part of her conditioning therapy may play a role. We suggest that vaginal stenosis may be under-reported, since female patients suffer a number of gynaecological complications after BMT, and that regular questioning and examination may aid in making an earlier diagnosis, allowing speedier instigation of therapy and thus improving quality of life.
Chronic graft-versus-host disease (cGVHD) is one of the most significant problems faced by allogeneic bone marrow transplant recipients and is reported to occur in 25-60% of the patients surviving for more than four months after allogeneic transplantation. 1 It may be of either a sclerodermatous or a lichenoid nature, or it may be a mixture of both types; many of the clinical features associated with cGVHD resemble those seen in various connective tissue disorders such as systemic sclerosis. We report the rare complication of vaginal stenosis which occurred in a 38-year-old female with acute myeloid leukaemia, following allogeneic BMT and suggest that this is likely to have been an isolated manifestation of cGVHD.
Case history
A 38-year-old female who in the past had had one pregnancy and a normal vaginal delivery with no complications Correspondence: Dr JG Treleaven, Department of Haematology, Royal Marsden NHS Trust, Downs Road, Sutton, Surrey SM2 5PT, UK Received 29 July 1998; accepted 11 October 1998 was diagnosed with acute myeloid leukaemia (AML M3) in April 1990 at her local hospital, where she was entered into the MRC AML 10 trial. She attained complete remission after one course of chemotherapy which comprised DAT 3 + 10 (daunorubicin, cytosine arabinoside and thioguanine) and then received consolidation therapy with two further courses of chemotherapy, DAT 2 + 8 and MACE (m-Amsa, adriamycin, cytosine arabinoside and etoposide). Apart from initial bleeding for the first 2 days of therapy due to diffuse intravascular coagulation, and an episode of pseudomonas septicaemia with the last course of treatment, she tolerated chemotherapy well and had no other complications.
In October 1990 she was referred to the Royal Marsden Hospital for allogeneic BMT from an HLA-compatible sibling. Melphalan 110 mg/m 2 and total body irradiation (TBI) 10.5 Gy were given as conditioning, with cyclosporin (CsA) (1.5 mg/kg from day 0 onwards) and methotrexate (MTX) (15 mg on day 1 and 10 mg from days 2-4) as GVHD prophylaxis. She had an uncomplicated course after BMT, and by day 19 her neutrophil count reached 0.5 × 10 9 /l. Five days later she was discharged, when the blood count revealed: Hb 10.5 g/dl, WBC 1.1 × 10 9 /l with 40% neutrophils and platelets 152 × 10 9 /l. There had been no evidence of skin, gut or liver GVHD and CsA levels were satisfactory.
Over the next 3-5 days, however, she developed diarrhoea and a fine papular rash over the forearms. Liver function tests were normal. A skin biopsy confirmed aGVHD, showing degeneration of the basal epidermal cells with a lymphocytic infiltrate of the dermis and positive immunostaining for HLA-DR antigens on epidermal cells. Treatment for this grade I/II aGVHD was commenced with methylprednisolone 1 g i.v. daily for 3 days, which led to resolution of the skin rash and diarrhoea. There was no recurrence, and CsA was gradually withdrawn from 5 months after BMT. A bone marrow examination performed 3 months later showed a cellular marrow in cytogenetic and morphological complete remission.
In July 1991 (10 months after BMT) she developed menopausal symptoms including hot flushes and sweats, vaginal dryness, dyspareunia and poor libido. Examination revealed a normal pelvis, vagina and cervix. Hormone replacement therapy (HRT) was started in the form of Premarin (Wyeth, Taplow, UK) 0.625 mg daily and Duphaston (Solvay, Southampton, UK) 10 mg from days 1-12. The sweats and flushes resolved, but the vaginal dryness worsened making penetration impossible. She also complained of amenorrhoea despite symptoms of menstruation.
Nearly 4 years later, in May 1995, she presented with severe lower back and abdominal pain in association with a brown vaginal discharge. Examination revealed a tender, boggy, ill-defined supra-pubic mass bulging at the vaginal introitus, which was thought to indicate a haematometra. A large fluid collection in the vagina was shown by ultrasound, with a distorted and displaced uterus and an obstructed endometrial cavity. This was consistent with a hydrometrocolpos, thought to be secondary to vaginal stricturing.
Urgent drainage of this collection was arranged, and at operation 750 ml of old blood and debris were drained after an incision had been made in the membrane at the introitus. Endometrial biopsy revealed menstrual phase endometrium but no neoplastic features. HRT with Prempak C (Wyeth) was restarted but there was still no withdrawal bleeding and she developed a recurrence of the haematocolpos. This was drained in October 1995 and vaginal adhesions in the lower vagina, approximately 3 cm above the introitus, were divided. She was instructed on self-dilation of the vagina. By December 1995 she had resumed normal menstrual flow with HRT and normal coital activity, while continuing with vaginal dilators.
She continued to experience post-coital bleeding, and examination in February 1996 revealed a mid-vaginal hourglass shaped stenosis with a lumen of approximately 1 cm. Over the next 2 years, however, this improved with the use of dilators and continued hormone replacement therapy, and the post-coital bleeding ceased.
A screen for auto-immune disorders (anti-nuclear antibodies, smooth muscle and mitochondrial antibodies and reticulin and gastric parietal cell antibodies) was negative, and thyroid function tests were normal.
Discussion
Sclerodermatous cGVHD may follow the lichenoid variant or it may occur de novo. It is so-called because its histological appearance resembles systemic sclerosis, with marked fibrosis and elastosis of the dermis accompanied by atrophy of skin adnexal structures and possibly the epidermis. These changes are reflected in the clinical appearance of tight, thick, shiny skin with alopecia in normally hairy areas which may be generalised or focal, and healing is extremely poor. Patients can develop blisters and/or skin ulceration.
Corson et al 2 in 1982 described the gyaenecologic manifestations of GVHD in five allogeneic BMT patients, and noted that the clinical symptoms and significant problems found in association with GVHD could include extensive sclerosing vaginitis and stricture formation. However, two of their patients who experienced vaginal stricture formation had not been exposed to total body irradiation during conditioning for their allogeneic BMTs, indicating that the process of stricture formation in both of these patients was likely to have been due principally to the cGVHD process. Both patients had experienced marked aGVHD and had many other stigmata of cGVHD, whereas our patient developed only grade II aGVHD in the immediate post-BMT period, which resolved promptly with additional steroid therapy, and she has no other symptoms or signs of cGVHD, normal thyroid function and a negative autoimmune screen.
Since vaginal stenosis is not a recognised complication of total body irradiation, and occurs most commonly in association with prior surgery for a fistula or for a congenital abnormality, in this context it is more likely to represent a manifestation of cGVHD, perhaps exacerbated by the total body irradiation, and the hormonal imbalance present after BMT which leads to atrophy of the vagina and glandular structures; this patient had had one uncomplicated vaginal delivery in the past. Interestingly, Kami et al 3 have reported a man who developed phimosis secondary to cGVHD and we have also seen such a case although, again, this is rare. However, the vaginal epithelium and that of the prepuce and glans is of a non-keratinizing squamous nature, so similar pathological changes after BMT in association with cGVHD are likely to occur in both.
The squamous epithelium of the oropharynx may also show similar changes to those seen in the skin generally. Chronic GVHD is more likely to affect them, producing atrophy of the glandular mucosa and duct ectasia, and a consequence of cGVHD affecting the oesophagus may be stricturing and dysphagia.
A biopsy of the tissue causing the stricture was not taken from this patient at surgery. However, since the histological changes of the skin in cGVHD show essentially increased fibrous tissue, the results of such a biopsy are unlikely to have clarified the cause of the stricture.
Skin which is damaged by either aGVHD, sun, or herpetic infections seems to be more susceptible to being involved by the cGVHD process, and there have also been reports of cGVHD occurring in an area previously affected by the rash of measles, 4 and also of GVHD occurring only in areas of skin which had been exposed to irradiation, 5, 6 or of it being exacerbated by radiation therapy. 7 Since in many respects, cGVHD mimics connective tissue disorders, and manifests with lichenoid and sclerotic changes in skin, muscle, tendons and ligaments, it seems likely that this patient's problem arose as a consequence of a relatively localised lichenoid manifestation of cGVHD which may have been exacerbated by the total body irradiation that she received as part of her conditioning therapy, in conjunction with post-menopausal vaginal dryness and atrophy coupled with loss of vaginal glandular tissue.
Earlier use of hormone replacement therapy and regular gynaecological follow-up may mitigate against the development of such situations or allow early diagnosis of impending problems and instigation of appropriate therapy. Since cGVHD occurs so frequently after allogeneic BMT, it seems likely that vaginal stricturing and stenosis are under-reported.
